SARS-CoV-2 RSS
Novavax, the recombinant nanoparticle Covid-19 vaccine.
Novavax is a new recombinant nanoparticle vaccine of coronavirus 2 (SARS-CoV-2) with an adjuvant, based on saponins extracted from the bark of Quillaja saponaria Molina that improves immune responses and allows for a reduction in the vaccine dose.
New monoclonal antibody designed to neutralize SARS-CoV-2
Monoclonal antibody therapy is a type of drug that can be used both to prevent SARS-CoV-2 infection and to treat it once the disease has developed.